Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
超越數字：7位分析師討論Silence Therapeutics股票
7 analysts have expressed a variety of opinions on Silence Therapeutics (NASDAQ:SLN) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有7位分析師對Silence Therapeutics（納斯達克股票代碼：SLN）表達了各種各樣的觀點，從看漲到看跌。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Silence Therapeutics, revealing an average target of $60.57, a high estimate of $75.00, and a low estimate of $42.00. This current average reflects an increase of 38.45% from the previous average price target of $43.75.
分析師已經爲Silence Therapeutics設定了12個月的目標股價，顯示平均目標股價爲60.57美元，最高估計爲75.00美元，低估值爲42.00美元。目前的平均價格比之前的平均目標價43.75美元上漲了38.45％。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
The analysis of recent analyst actions sheds light on...
對分析師最近行爲的...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。